| Patents for C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718) |
|---|
| 08/31/2005 | CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 08/31/2005 | CN1660847A Folic acid |
| 08/25/2005 | CA2555597A1 Radiolabeled compounds and compositions, their precursors and methods for their production |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
| 08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 08/24/2005 | EP1216246B1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 08/24/2005 | CN1659169A Riboflavin derivative and its preparation method and uses |
| 08/23/2005 | US6933285 Flavin N-oxides: new anti-cancer agents and pathogen eradication agents |
| 08/17/2005 | CN1215061C Process for preparing anticancer compound, and intermediate |
| 08/17/2005 | CN1214788C Compositions for treatment and prevention of cardiovascular diseases |
| 08/11/2005 | WO2005046588A3 Compounds, compositions, and methods |
| 08/04/2005 | US20050171348 Adding an organic acid to a non-alkaline suspension of (6S,6R)-5,6,7,8-tetraydrofolic acid, up to a pH value in the range of 1 to 3; heating the suspension from 30 degrees to 80 degrees C.; cooling the suspension from 20 degrees to 60 degrees C., with selective crystallization of the (6S)-isomer |
| 08/04/2005 | US20050171345 Pteridine compounds for the treatment of psoriasis |
| 08/03/2005 | EP1558083A2 Compounds, compositions, and methods |
| 07/28/2005 | WO2005068465A1 2-amino-o4-substituted pteridines and their use as inactivators of o6-alkylguanine-dna alkyltransferase |
| 07/28/2005 | US20050165227 Antiproliferative agents; gene overexpression |
| 07/28/2005 | CA2552826A1 2-amino-o4-substituted pteridines and their use as inactivators of o6-alkylguanine-dna alkyltransferase |
| 07/27/2005 | EP0986561B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/26/2005 | US6921754 Compositions containing folic acid and reduced folate |
| 07/21/2005 | WO2005065018A2 Crystalline forms of (6r) -l-erythro-tetrahydrobiopterin dihydrochloride |
| 07/21/2005 | US20050159570 Molecularly imprinted polymer obtainable by polymerization of hexamethyl phosphonamide based monomer in presence of a template molecule and extraction; crosslinking; separation of enantiomers, resolution |
| 07/21/2005 | CA2678165A1 Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride |
| 07/21/2005 | CA2678125A1 Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride |
| 07/21/2005 | CA2678124A1 Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride |
| 07/20/2005 | EP1555025A2 Use of dehydroepiandrosterone analogs for the treatment of asthma |
| 07/20/2005 | EP1221982B1 Isoalloxazine derivatives to neutralize biological contaminants |
| 07/14/2005 | WO2005063752A1 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level |
| 07/13/2005 | EP1553099A1 A riboflavin derivative and its manufacture and uses |
| 07/07/2005 | WO2005042498A3 4-amino (aza) quinoline derivatives as capsaicin receptor agonists |
| 07/07/2005 | US20050148593 Compounds, compositions, and methods |
| 07/07/2005 | US20050148592 Use of riboflavin and flavin derivatives as chitinase inhibitors |
| 07/06/2005 | CN1633991A Granular folacin production method and product |
| 06/30/2005 | WO2005025574A3 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 06/30/2005 | WO2004100960A8 Anti-inflammatory phosphonate compounds |
| 06/30/2005 | WO2004096236A3 Immunomodulator phosphonate conjugates |
| 06/22/2005 | EP1007533B1 Bioconjugates and delivery of bioactive agents |
| 06/21/2005 | CA2213339C Method of treating adenosine depletion |
| 06/16/2005 | WO2005032481A3 Quinazoline derivatives as medicaments |
| 06/16/2005 | WO2004096286A3 Antiviral phosphonate analogs |
| 06/15/2005 | CN1206229C Method for making pure stereoisomers of tetrahydrofolic acid ester salts and tetrahydrofolic acid by fractionated crystallisation of tetrahydrofolic acid salts |
| 06/09/2005 | WO2005021003A3 Immunosuppressive effects of pteridine derivatives |
| 06/09/2005 | US20050123597 Releasable linkage and compositions containing same |
| 06/08/2005 | EP1537089A2 Compounds compositions and methods |
| 06/02/2005 | WO2005049614A2 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin |
| 06/02/2005 | WO2004089889A3 Method for the production of riboflavin of modification b/c in granular form |
| 06/02/2005 | US20050119269 Heterocyclic compounds and methods of making and using thereof |
| 06/02/2005 | CA2545484A1 Processes for preparing tetrahydrobiopterin, and analogs of tetrahydrobiopterin |
| 05/31/2005 | US6900180 Mixture of folic acid, vitamin b6 and b12 with carbohydrates, fats and proteins; infant formula; sleep disorders |
| 05/26/2005 | WO2005046698A1 Fused heterocyclic compounds |
| 05/26/2005 | WO2005046588A2 Compounds, compositions, and methods |
| 05/26/2005 | CA2545340A1 Fused heterocyclic compounds |
| 05/25/2005 | EP1532209A2 Charge transport compositions and electronic devices made with such compositions |
| 05/25/2005 | EP1531823A2 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents |
| 05/24/2005 | US6897315 Method for producing 8-methoxy-quinolinecarboxylic acids |
| 05/18/2005 | EP0884317B1 Active oxygen scavengers containing pterin derivatives |
| 05/12/2005 | WO2005042498A2 4-amino (aza) quinoline derivatives as capsaicin receptor agonists |
| 05/12/2005 | WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof |
| 05/12/2005 | US20050100611 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 05/12/2005 | CA2540342A1 4-amino (aza) quinoline derivatives as capsaicin receptor agonists |
| 05/11/2005 | EP1004308B1 Preventives or remedies for drug-induced renal disturbance |
| 05/11/2005 | CN1200938C Process for preparing 8-methoxy-quinolone |
| 05/06/2005 | WO2005040163A1 Heterocyclic compounds that block the effects of advanced glycation end products (age) |
| 05/06/2005 | WO2005039587A1 Heterocycle-substituted pteridine derivatives and their use in therapy |
| 05/06/2005 | WO2004096287A3 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| 05/06/2005 | CA2537224A1 Heterocycle-substituted pteridine derivatives and their use in therapy |
| 05/05/2005 | US20050096333 Quinazoline derivatives as medicaments |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2005 | EP1143974B1 Pharmaceutical compositions for alleviating discomfort |
| 04/27/2005 | EP1034173B1 Method for producing 8-methoxy-quinoline carboxylic acids |
| 04/27/2005 | CN1198595C Process for preparation of spraying granule of ovoflaving |
| 04/26/2005 | US6884477 Electroluminescence device using liquid crystal compound |
| 04/14/2005 | WO2005033115A1 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 04/14/2005 | WO2005032481A2 Quinazoline derivatives as medicaments |
| 04/14/2005 | CA2541533A1 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 04/06/2005 | EP1520452A2 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/06/2005 | EP1520308A2 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/06/2005 | EP1520305A2 Charge transport compositions and electronic devices made with such compositions |
| 04/06/2005 | EP1519935A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 04/05/2005 | US6875868 Pteridine compounds for the treatment of psoriasis |
| 04/05/2005 | US6875769 Substituted6,6-hetero-bicyclicderivatives |
| 04/05/2005 | US6875766 Use of riboflavin and flavin derivatives as chitinase inhibitors |
| 04/05/2005 | US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 03/24/2005 | WO2005025574A2 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 03/24/2005 | WO2004043338A3 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents |
| 03/22/2005 | US6870021 Mixtures of condensation polymers comprising organonitrogen or organosulfur polymers and curing agents, having preferential binding, used for analysis, separation and resolution of racemic mixtures |
| 03/22/2005 | US6869955 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
| 03/17/2005 | US20050059662 Substituted quinazolinone compounds |
| 03/16/2005 | EP1513820A2 Compounds, compositions, and methods |
| 03/15/2005 | CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones |
| 03/10/2005 | WO2005021003A2 Immunosuppressive effects of pteridine derivatives |
| 03/10/2005 | WO2004112793B1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 03/10/2005 | US20050054653 Pteridine derivatives, method of producing them and their application |
| 03/09/2005 | CN1191861C Medicinal compositions containing anti-Fas antibody |
| 03/03/2005 | WO2005018531A2 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof |
| 03/02/2005 | CN1587264A Polyglycol derivative of methotrexate and its preparing method |
| 03/02/2005 | CN1191236C Substituted 6,6-Hetero-dicycloderivative |
| 03/01/2005 | US6861514 The folate can be attached via the alpha - or gamma -carboxylate, optionally through a linking group. |
| 03/01/2005 | US6861422 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 02/24/2005 | WO2004096235A8 Anti-cancer phosphonate analogs |
| 02/23/2005 | CN1583746A Methylamino-pterin derivative with inhibiting nitric oxide synthetase function |